Availability of Background Document for Joint Meeting of Nonprescription Drugs Advisory Committee and Pulmonary-Allergy Drugs Advisory Committee

Summary

The Food and Drug Administration has made available a background document for the joint meeting of the Nonprescription Drugs Advisory Committee and the Pulmonary-Allergy Drugs Advisory Committee to discuss over-the-counter marketing of antiasthma drug products.